on 10 Apr 2024
Last Applicant/ Owned by
400 Monroe Avenue, N.W.
Grand Rapids
US
49503
Serial Number
98121991 filed on 08th Aug 2023
Registration Number
N/A
Correspondent Address
TIMOTHY E. EAGLEVARNUM LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing online non-downloadable molecular imaging data interpretation software; nuclear medicine services, namely, radioactive tracer research and product development for others Molecular imaging based diagnosis and therapy; molecular imaging clinical operations in the nature of medical services Radiopharmacy business administration and management services Color is not claimed as a feature ofRead More
Molecular imaging based diagnosis and therapy; molecular imaging clinical operations in the nature of medical services
Providing online non-downloadable molecular imaging data interpretation software; nuclear medicine services, namely, radioactive tracer research and product development for others
Radiopharmacy business administration and management services
Contract radioactive tracer manufacturing for others
Nuclear medicine products, namely, pharmaceutical preparations for diagnosing and treating cancer, neurodegenerative diseases, cardiac disease, post traumatic stress disorder and pain; nuclear medicine products, namely, radioactive tracers
No 98121991
No Service Mark
No BAM T3US1
No
No
No
No
No
No
No
No
26.01.02 -
Plain single line circles
26.01.11 -
Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle
26.01.12 -
Circles with bars, bands and lines
26.01.28 -
Miscellaneous circular designs with an irregular circumference
26.11.27 -
Oblongs not being used as carriers for words, letters or designs
Status Date | Action Taken |
---|---|
24th Apr 2024 | NOTIICATION O NOTICE O PUBLICATION E-MAILE |
09th Apr 2024 | APPROVE OR PUB - PRINCIPAL REGISTER |
09th Apr 2024 | ASSIGNE TO EXAMINER |
07th Sep 2023 | NOTICE O ESIGN SEARCH COE E-MAILE |
06th Sep 2023 | NEW APPLICATION OICE SUPPLIE ATA ENTERE |
11th Aug 2023 | NEW APPLICATION ENTERE |